Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1607 (LINC01607) is a gene encoding a long intergenic non-coding RNA (lincRNA) transcript, which does not overlap with protein-coding genes and does not encode a protein[1][3][5]. LINC01607 is part of a family of non-coding RNAs that are transcribed by RNA polymerase II and are generally longer than 200 nucleotides[3][5]. These RNA molecules can participate in gene regulation, chromatin remodeling, and modulate cell differentiation, although the specific function of LINC01607 is currently unknown[1][3]. While lincRNAs as a class play diverse regulatory roles—sometimes in cell fate, cancer, and developmental processes—no direct association of LINC01607 with disease, drug interactions, or therapeutic targeting is reported in authoritative databases at present[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1607 (LINC01607).